Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancer [clinicaltrials:NCT00014352]
Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancer [clinicaltrials:NCT00014352]
Bio2RDF identifier
NCT00014352
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00014352
identifiers.org URI
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
RATIONALE: Drugs used i ...... nts who have prostate cancer.
brief title [clinicaltrials_vocabulary:brief-title]
Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancer
collaborator [clinicaltrials_vocabulary:collaborator]
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
OBJECTIVES: I. Determin ...... for this study within 1 year.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2001-04-10T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
keyword [clinicaltrials_vocabulary:keyword]
recurrent prostate cancer
stage III prostate cancer
stage IV prostate cancer
thromboembolism
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2013-01-15T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
link [clinicaltrials_vocabulary:link]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00014352
official title [clinicaltrials_vocabulary:official-title]
Phase II Trial Of Sequential E ...... en-Independent Prostate Cancer
org study id [clinicaltrials_vocabulary:org-study-id]
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
primary completion date [clinicaltrials_vocabulary:primary-completion-date]
2003-03-01T00:00:00Z
secondary id [clinicaltrials_vocabulary:secondary-id]
MSKCC-00113
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
2000-09-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2013-01-01T00:00:00Z
identifier
clinicaltrials:NCT00014352
title
Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancer
@en
type
label
Combination Chemotherapy Plus ...... r [clinicaltrials:NCT00014352]
@en